Side-by-side comparison
MOTS-c vs SS-31 — Price & Profile Comparison
MOTS-c
Metabolic PeptideMitochondrial research
SS-31
Mitochondrial PeptideMitochondrial research
The short answer
MOTS-c vs SS-31: which to choose
On price they're close — about $16 vs $17 for the cheapest COA-verified listing. MOTS-c is the more widely stocked of the two (55 vendors vs 37). They target different goals — MOTS-c is a metabolic peptide compound while SS-31 is a mitochondrial peptide one — so they're often complementary rather than direct substitutes.
Research products are not for human use. Looking for clinician-supervised care instead? Compare licensed US telehealth programs that may offer provider-guided peptide protocols when clinically appropriate.
Compare supervised options →Price Comparison — 2026
MOTS-c
SS-31
Vendors Carrying Both
33 vendors stock both MOTS-c and SS-31 — convenient if you want to bundle an order.
Safety Notes
MOTS-c
FDA: Not FDA-approved
Endogenous mitochondrial peptide; human study showed safety in metabolic syndrome; promising early data
SS-31
FDA: FDA-approved (Barth Syndrome)
FDA-approved Sept 2025; 600+ patients in trials; injection site reactions main AE; well-tolerated
